tetano
Editor, Senior Moderator
Influenza Other Respir Viruses. 2016 Nov 8. doi: 10.1111/irv.12436. [Epub ahead of print]
[h=1]Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015.[/h] McAnerney JM[SUP]1[/SUP], Walaza S[SUP]1[/SUP], Tempia S[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Blumberg L[SUP]1[/SUP], Treurnicht FK[SUP]1[/SUP], Madhi SA[SUP]1,[/SUP][SUP]4[/SUP], Valley-Omar Z[SUP]1,[/SUP][SUP]5[/SUP], Cohen C[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Trivalent seasonal influenza vaccine effectiveness during the 2015 season in South Africa was assessed using a test-negative case control study design. Influenza A(H1N1)pdm09 was the dominant circulating strain. Overall influenza vaccine coverage was 3.2% (29/899). The vaccine effectiveness estimate, against any influenza virus infection, adjusted for age, underlying conditions and timing within season was 46.2% (95% CI: -23.5% to 76.5%), and 53.6% (95% CI: -62.6% to 80.3%) against influenza A(H1N1)pdm09. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
PMID: 27865064 DOI: 10.1111/irv.12436
[PubMed - as supplied by publisher] Free full text
[h=1]Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015.[/h] McAnerney JM[SUP]1[/SUP], Walaza S[SUP]1[/SUP], Tempia S[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Blumberg L[SUP]1[/SUP], Treurnicht FK[SUP]1[/SUP], Madhi SA[SUP]1,[/SUP][SUP]4[/SUP], Valley-Omar Z[SUP]1,[/SUP][SUP]5[/SUP], Cohen C[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Trivalent seasonal influenza vaccine effectiveness during the 2015 season in South Africa was assessed using a test-negative case control study design. Influenza A(H1N1)pdm09 was the dominant circulating strain. Overall influenza vaccine coverage was 3.2% (29/899). The vaccine effectiveness estimate, against any influenza virus infection, adjusted for age, underlying conditions and timing within season was 46.2% (95% CI: -23.5% to 76.5%), and 53.6% (95% CI: -62.6% to 80.3%) against influenza A(H1N1)pdm09. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
PMID: 27865064 DOI: 10.1111/irv.12436
[PubMed - as supplied by publisher] Free full text